Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Creatine valinate is a synthetic derivative of creatine, typically structured as an ester or salt of creatine with the amino acid L-valine. Developed primarily for the sports nutrition market, this compound is designed to overcome the solubility and absorption limitations associated with standard creatine monohydrate. The inclusion of the valine moiety is intended to enhance the molecule's lipophilicity or allow it to utilize alternative absorption pathways, such as the peptide transporter PEPT1, thereby increasing the efficiency of creatine delivery to skeletal muscle. Once absorbed and hydrolyzed, it provides creatine to the phosphocreatine pool, which is essential for the rapid regeneration of adenosine triphosphate (ATP) during short bursts of high-intensity exercise.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on creatine valinate.